The American Venous Forum announces new $50,000 fellowship, provided by Janssen Pharmaceuticals, to develop new mechanisms for data collection. Applications are being accepted until August 20, 2021.
The American Venous Forum (AVF) is dedicated to the diagnosis, treatment and prevention of venous disease, including the incidence of venous thromboembolism (VTE) leading to fatal pulmonary emboli (PE) – the leading preventable cause of death in hospitalized patients.
One key to prevention is performing a thorough risk assessment. The Caprini Risk Score (CRS), developed by AVF Past President Joseph A. Caprini MD, incorporates 40 risk factors and has been tested in more than 5,000,000 patients worldwide in both medical and surgical populations.
A multidisciplinary CRS-AVF committee of more than 30 members from around the world is currently working on improvements to the current Caprini score. A key component of this initiative is to devise ways to collect data using a variety of methods, including machine learning tools that have been shown to not only facilitate data collection but also to serve as good predictive models based on proper input.
The American Venous Forum, through generous support from Janssen Pharmaceuticals, has established a new AVF-Janssen Fellowship which will award $50,000 to develop unique mechanisms for data collection. The goal of this fellowship include:
- Support the CRS-AVF initiative to create an updated score
- Develop unique mechanisms for data collection
- Using proven machine learning tools, create a prediction tool for VTE to further improve the sensitivity of the CRS.
- Example 1: “A Machine Learning Approach to Predict Deep Venous Thrombosis Among Hospitalized Patients”
- The applicant, as lead researcher, must be a fellow in a recognized fellowship program located in the United States with a minimum of two additional trainees and an established mentor.
- Applicants must attest, in their cover letter, that they are not currently excluded by the Office of the Inspector General from participation in Medicare, Medicaid, or other Federal health care programs and that both the applicant and their institution are not currently included on the FDA department list or the EPLS list.
- Applicants are required to include a letter from the Program Director confirming a twelve-month commitment to the project and enough time dedicated to research during this period.
- The applicant must demonstrate their abilities and availability to begin this project by October 1, 2021 and complete the project within 12 months.
- The awardee would be expected to present their report at the next annual AVF Meeting following project completion – either February 2022 or February 2023, depending on the scope and timeline of the awarded Fellowship.
- The awardee agrees to submit their results for publication in the Journal of Vascular Surgery Venous and Lymphatic Disease.
- The awardee would be expected to become a member of the American Venous Forum and maintain that membership through their report at the AVF Annual Meeting,
- The awardee’s institution must provide a signed W-9 prior to the initial disbursement. Subsequent requests for disbursement after six months and after completion must be accompanied by a formal letter of request for funding, an itemized invoice correlating to the originally submitted budget, and update on the status of the research project.
- The grant award WILL NOT pay for indirect costs to the researcher’s university or facility.
- Applicants must complete and submit the fellowship application.
- A layman’s summary of the grant proposal should be included with the Application.
- The sponsor (mentor) of the project is required to submit a letter of support and verification of resources available to support the project.
- The applicant must submit their curriculum vitae.
- All documents should be submitted to Jeff Mendola, Director of Mission Advancement, at Jeff@VeinForum.org.
- Application Deadline is 5pm (CST) on Friday, August 20, 2021
- Significance of proposed project and match with desired outcomes.
- Approach including framework, design, methods, and level of innovation.
- Is the applicant appropriately trained?
- Is the proposed work appropriate to the experience level of the applicant and the complementary and integrated expertise of the investigative team?
- Does their scientific environment and mentor contribute positively to their probability of success?
- Does the applicant have an opportunity to grow as a specialist/scientist through the implementation of this project?